Documentation of biological therapies in chronic rhinosinusitis with   nasal polyposis (CRSwNP): dupilumab, omalizumab and mepolizumab

Document type:: Article
Author(s):: Klimek, Ludger; Foerster-Ruhrmann, Ulrike; Beule, Achim G.; Chaker, Adam M.; Hagemann, Jan; Klimek, Felix; Casper, Ingrid; Huppertz, Tilman; Hoffmann, Thomas K.; Dazert, Stefan; Deitmer, Thomas; Olze, Heidi; Strieth, Sebastian; Wrede, Holger; Schlenter, Wolfgang; Welkoborsky, Hans-Juergen; Wollenberg, Barbara; Bergmann, Christoph; Cuevas, Mandy; Beutner, Caroline; Groeger, Moritz; Becker, Sven
Title:: Documentation of biological therapies in chronic rhinosinusitis with nasal polyposis (CRSwNP): dupilumab, omalizumab and mepolizumab
Journal title abbreviation:: Allergo J
Year:: 2022
Journal volume:: 31
Journal issue:: 6
Pages contribution:: 24-38
Fulltext / DOI:: doi:10.1007/s15007-022-5080-1
Pubmed ID:: http://view.ncbi.nlm.nih.gov/pubmed/36092307
TUM Institution:: 1212; 284; 599; Klinik und Poliklinik für Hals-, Nasen- und Ohrenheilkunde (Prof. Wollenberg); Lehrstuhl für Molekulare Allergologie und Umweltforschung (Prof. Schmidt-Weber)
BibTeX